10,989,344 Shares in Avantor, Inc. $AVTR Acquired by Bank of America Corp DE

Key Points

• Bank of America acquired 10.99 million Avantor shares worth approximately $108.8 million, giving it a 1.62% stake. Other institutions also initiated positions, and institutional investors collectively own 95.08% of the company.
• Analysts remain broadly neutral on Avantor, with 15 Hold, two Buy, and one Sell rating; the consensus price target is $12.47.
• Avantor reported quarterly earnings of $0.21 per share, beating estimates by $0.02, while revenue reached $1.69 billion. Shares opened at $15.51, near the company’s 52-week high of $16.05.

Bank of America Corp DE acquired a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,989,344 shares of the company's stock, valued at approximately $108,795,000. Bank of America Corp DE owned 1.62% of Avantor as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Freestone Grove Partners LP bought a new position in shares of Avantor in the second quarter valued at $56,577,000. Man Group plc bought a new stake in Avantor during the 2nd quarter worth approximately $9,806,000. Jupiter Topco LLC bought a new stake in Avantor during the 2nd quarter worth approximately $3,047,000. ADAR1 Capital Management LLC purchased a new position in shares of Avantor during the second quarter valued at approximately $1,287,000. Finally, Hsbc Holdings PLC purchased a new stake in Avantor in the 2nd quarter valued at $332,000. Institutional investors own 95.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AVTR shares. Royal Bank Of Canada lifted their price objective on shares of Avantor from $9.00 to $14.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Wells Fargo & Company raised their price target on shares of Avantor from $14.00 to $16.00 and gave the company an "overweight" rating in a research report on Thursday, July 30th. Wolfe Research upgraded shares of Avantor from a "strong sell" rating to a "hold" rating in a report on Thursday, July 30th. Sanford C. Bernstein began coverage on shares of Avantor in a research report on Friday, June 26th. They issued a "market perform" rating and a $10.50 price objective for the company. Finally, TD Cowen reissued a "hold" rating on shares of Avantor in a research report on Wednesday, July 15th. Two research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $12.47.

Avantor Stock Down 2.2%

Shares of NYSE AVTR opened at $15.51 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The company has a market cap of $10.49 billion, a P/E ratio of -18.46, a P/E/G ratio of 11.97 and a beta of 0.89. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $16.05. The business has a 50-day simple moving average of $13.63 and a two-hundred day simple moving average of $10.36.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.61 billion. During the same period in the prior year, the business posted $0.24 earnings per share. The company's revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Research analysts anticipate that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc NYSE: AVTR is a global provider of products and services used in the life sciences, healthcare and advanced technology industries. The company supports research, drug discovery, biopharmaceutical production, clinical and diagnostic activities, and other laboratory-based applications.

Its offerings include laboratory chemicals and reagents, consumables, equipment, instruments, production materials and related services. Avantor also provides supply-chain, procurement and other technical solutions designed to help customers manage laboratory and manufacturing operations.

Avantor serves customers across pharmaceutical and biopharmaceutical companies, healthcare providers, academic and government institutions, medical laboratories and industrial businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.